Lice-Fighting Nix Offers Coupons To "Matilda" Ticketholders
Lice are creepy - but they're no reason to miss such a great show
TREVOSE, Pa., May 9, 2014 /PRNewswire/ -- Nix, the over-the-counter lice-fighting treatment most recommended by pharmacists, is coming to Broadway's aid after a lice outbreak.
This week's New York Post reported on Page Six that at least six of the stars of "Matilda the Musical" had been caught up in a lice outbreak.
"Reading about head lice makes your skin crawl," said Brad Doyle, Nix senior brand manager. "Lice are creepy for sure – but they're no reason to miss a great show like 'Matilda.'"
"Since the 'show must go on,' Nix is offering a hefty $3 coupon for its famous head lice treatment to anyone who has a ticket to Matilda and is creeped out by the lice," Doyle continued. "Just tweet a picture of your Matilda ticket to @Nix_Tix and we'll reply back with the $3 coupon."
"Nix is a powerful first line of defense against head lice. It gives you peace of mind, knowing you've done everything you can to protect yourself. So you can head off to the show with a spring in your step – and no compulsive need to itch. We'll see you at the show!"
About Nix:
Nix® has been the #1 pharmacist-recommended lice treatment brand for more than 15 years. The medicine in Nix® is recognized as the most effective over-the-counter treatment for killing lice and their eggs according to the Academy of Pediatrics, and its maximum strength formula protects against lice reinfestation for up to 14 days. Nix® is recommended by pharmacists…trusted by moms…and hated by lice.
About Insight Pharmaceuticals:
INSIGHT Pharmaceuticals, LLC is a consumer products company whose strategy is to generate growth by acquiring brands with solid consumer equity that can be further developed through their merchandising and marketing expertise. The company strengthens its portfolio of brands by employing a variety of strategies, all with an in-depth understanding of the heritage of the brand and the needs of the consumer. Additional information about Insight Pharmaceuticals can be found at www.InsightPharma.com.
Media Contact:
Kaitlin Bitting
Allen & Gerritsen
[email protected]
856-986-4206
Company Contact:
Brad Doyle
Insight Pharmaceuticals
[email protected]
267-852-0505
SOURCE Nix
Share this article